Friday, 26 June 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 26 June 2026
Vivacity
Vivacity
Two days, two big deals for Arrotex

It's been quite the week for Arrotex. Despite the exit of its CEO, the company has unveiled two major innovative medicine deals, the latest putting it in a market dominated by the world's biggest pharmas.

Why pharma strategies are failing
The gap between strategic intent and execution is widening as demand for transformation grows faster than leadership capacity
TODAY
Look who's moving its HQ to the US
Australian radiopharma is setting up its global headquarters in Boston as it takes on the big guns, including Novartis
TODAY
Lilly says 'No' to Aussie drug launch
This new drug will not reach Aust in the foreseeable future as Lilly continues its stance against the nation's reimbursement system
25 June
Arrotex inks first-to-market deal
Arrotex has lost its CEO, but the deals keep coming with an exclusive agreement to bring first-to-market therapy eye to Australia
25 June
Second ANZ Leader resigns in 24 hours
A local GM has decided to seek other opportunities rather than take up an expanded role in a restructured company
24 June
Another Country Leader departs
After just seven months in the top job and less than a year since resigning from his previous role, this ANZ leader is moving on
24 June
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (20)

Access & Reimbursement (2)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (6)

Executive Roles (5)

Other (12)

Pharma joins Ebola fight
Companies step up efforts to battle the deadly disease with WHO announcing two drugs will be trialled from next week
25 June
Companies eye monster market
With a trump card in the form of a superior safety profile, this partnership is ready to crack a lucrative market
25 June
Aussie drug heads to LA
A promising new cancer treatment developed by Aussie researchers has been acquired for an undisclosed price
25 June
July PBS wait list swells to 18
Eighteen submissions recommended by the PBAC have progressed to the final stage ahead of a possible PBS listing next month
24 June
Burnout stories from the frontline
Australian pharma professionals have lifted the lid on workload and burnout within companies with an expert revealing how to lighten the load
24 June
Dept preps for more broad listings
Govt issues guidelines for pharmas wanting to win a broad listing for their anti-cancer drug but there's a catch with pricing
24 June
AbbVie pays big for major market
Pharma drops $15.6 billion for a challenger to Dupixent in atopic dermatitis, which it hopes will become a mega-blockbuster
24 June
Which Aussie Drs love seeing Reps?
Survey reveals which healthcare practitioners most prefer to get medical information from pharma reps, and by how much
23 June
Mega pays are not just for CEOs
You don't have to be CEO to earn a whopper salary - 10 scientists and doctors in Big Pharma have hit the jackpot with earnings of more than $AU14M last year
23 June
Company beefs up Access role
With market access an ever-growing pain point for industry, one company has broadened this function. See who's leading the new team
23 June
ASCO Breakthrough hits Singapore
Conference kicks off in Singapore for the first time with oncologists exploring region-focused treatments, and how to expand personalisation
23 June
Funding failures hurt productivity
MA report highlights the ripple effect of delayed access to innovative medicines, extending far beyond health outcomes
23 June
Another pharma cuts Aussie jobs
Yet another Big Pharma has downsized its Australian workforce as part of a global restructure designed to realign resources
22 June
Novo hit with $105M ransom demand
The company's biggest secrets - including "confidential recipes" for its top drugs appear to be for sale on the Dark Web after the company refused hackers' demands
22 June
PiF Advertise
PiF Advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.